Phase II trials of trimetrexate in advanced adult soft tissue sarcoma. Studies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group.
Eisenhauer
E A
EA
National Cancer Institute of Canada Clinical Trials Group, Queen's University, Kingston, Ontario.
Wierzbicki
R
R
Knowling
M
M
Bramwell
V H
VH
Quirt
I C
IC
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002170:Canada; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006077:Government Agencies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*; D016597:Trimetrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D016597:Trimetrexate